The stock of Heart Test Laboratories Inc (NASDAQ: HSCS) has increased by 3.40 when compared to last closing price of 0.15. Despite this, the company has experienced a -16.16% fall in its stock price over the last five trading sessions. InvestorPlace reported 2023-11-15 that Heart Test Laboratories (NASDAQ: HSCS ) stock is rising higher on Wednesday without any clear news from the maker of cardiovascular diagnostic devices. There have been no new press releases or filings with the Securities and Exchange Commission that explain why HSCS stock is rising higher today.
Is It Worth Investing in Heart Test Laboratories Inc (NASDAQ: HSCS) Right Now?
The 36-month beta value for HSCS is also noteworthy at 3.60. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The average price estimated by analysts for HSCS is $3.80, which is $3.64 above than the current price. The public float for HSCS is 7.47M, and at present, short sellers hold a 0.63% of that float. The average trading volume of HSCS on November 16, 2023 was 2.94M shares.
HSCS’s Market Performance
HSCS stock saw a decrease of -16.16% in the past week, with a monthly decline of -58.70% and a quarterly a decrease of -78.46%. The volatility ratio for the week is 31.44%, and the volatility levels for the last 30 days are 29.95% for Heart Test Laboratories Inc (HSCS). The simple moving average for the past 20 days is -34.25% for HSCS’s stock, with a -83.13% simple moving average for the past 200 days.
HSCS Trading at -61.20% from the 50-Day Moving Average
After a stumble in the market that brought HSCS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -96.07% of loss for the given period.
Volatility was left at 29.95%, however, over the last 30 days, the volatility rate increased by 31.44%, as shares sank -59.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -80.48% lower at present.
During the last 5 trading sessions, HSCS fell by -16.65%, which changed the moving average for the period of 200-days by -91.88% in comparison to the 20-day moving average, which settled at $0.2246. In addition, Heart Test Laboratories Inc saw -81.53% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for HSCS
Current profitability levels for the company are sitting at:
- -118698.33 for the present operating margin
- -476.91 for the gross margin
The net margin for Heart Test Laboratories Inc stands at -123384.27. Equity return is now at value -519.34, with -150.59 for asset returns.
Based on Heart Test Laboratories Inc (HSCS), the company’s capital structure generated 679.17 points at debt to equity in total, while total debt to capital is 87.17. Total debt to assets is 47.63, with long-term debt to equity ratio resting at 450.24. Finally, the long-term debt to capital ratio is 57.69.
When we switch over and look at the enterprise to sales, we see a ratio of 935.96, with the company’s debt to enterprise value settled at 0.22. The receivables turnover for the company is 4.44 and the total asset turnover is 0.00. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.38.
In summary, Heart Test Laboratories Inc (HSCS) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.